|
|
||||
|
|
||||
|
||||
Medical Neuro-Oncology |
The Preuss Laboratory for Molecular Neuro-Oncology, Brain Tumor Research Center (H.K., N.K., M.A.I.); Department of Neurological Surgery, University of California, San Francisco, CA 94143 (H.K., K.R.L., N.K., M.A.I.); Mayo Clinic and Foundation, Rochester, MN 55905 (J.R.O., N.I., T.S., B.W.S., J.C.B., R.B.J.); Toledo Community Hospital Oncology Program, Toledo, OH 43623 (P.L.S.)
2 Address correspondence and reprint requests to Mark A. Israel, Norris Cotton Cancer Center, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, 1 Medical Center Dr., Lebanon, NH 03756.
Abstract
We evaluated the association of spontaneous apoptosis and an apoptosis/proliferation index with survival to determine the potential of such measures to serve as predictive markers for patients with glioblastoma multiforme (GBM). We examined the extent of spontaneous apoptosis in tumors from newly diagnosed patients, 75 with GBM and 21 with anaplastic astrocytoma, who were entered on treatment protocols of the North Central Cancer Treatment Group. In the group of GBM patients, those with a higher apoptotic index tended to live longer (P = 0.04; Cox proportional hazards model including performance score, age, and extent of resection in a multivariate model). We found that the apoptotic index values for anaplastic astrocytoma patients tended to be lower than those in the GBM patients, although with small sample sizes, the result was not statistically significant (P = 0.1). We also examined expression of the Ki-67 cell proliferation antigen immunohistochemically using the MIB-1 monoclonal antibody. Ki-67 expression did not provide additional information regarding the survival of patients with GBM. In this group of GBM patients, those patients with higher apoptotic index/proliferation ratios had a better prognosis than did those with a low ratio (P < 0.021, same model as above). These findings suggest that both apoptosis and a cell death/cell proliferation ratio are associated with patient survival, and they may be useful for either the clinical evaluation of patients with GBM or the stratification of patients for treatment evaluation.
References
Chung, E.J., Seong, J., Yang, W.I., Park, T.K., Kim, J.W., Suh, C.O., and Kim, G.E. (1999) Spontaneous apoptosis as a predictor of radiotherapy in patients with stage IIB squamous cell carcinoma of the uterine cervix. Acta Oncol. 38,449 -454.[CrossRef][ISI][Medline]
Cunningham, J.M., Kimmel, D.W., Scheithauer, B.W., O'Fallon, J.R., Novotny, P.J., and Jenkins, R.B. (1997) Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: Relationships and prognostic value. J. Neurosurg. 86,121 -130.[ISI][Medline]
Desoize, B. (1994) Anticancer drug resistance and inhibition of apoptosis. Anticancer Res. 14,2291 -2294.[ISI][Medline]
Ellison, D.W., Steart, P.V., Gatter, K.C., and Weller, R.O. (1995) Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Neuropathol. Appl. Neurobiol. 21,352 -361.[Medline]
Fisher, D.E. (1994) Apoptosis in cancer therapy: Crossing the threshold. Cell 78,539 -542.[CrossRef][ISI][Medline]
Ganju, V., Jenkins, R.B., O'Fallon, J.R., Scheithauer, B.W., Ransom, D.T., Katzmann, J.A., and Kimmel, D.W. (1994) Prognostic factors in gliomas: A multivariate analysis of clinical, pathologic, flow cytometric, cytogenetic, and molecular markers. Cancer 74,920 -927.[CrossRef][ISI][Medline]
Gorczyca, W., Tuziak, T., Kram, A., Melamed, M.R., and Darzynkiewicz, Z. (1994) Detection of apoptosis-associated DNA strand breaks in fine-needle aspiration biopsies by in situ end labeling of fragmented DNA. Cytometry 15,169 -175.[CrossRef][ISI][Medline]
Grzybicki, D.M., and Moore, S.A. (1999) Implications of prognostic markers in brain tumors. Clin. Lab. Med. 19,833 -847.[Medline]
Haapasalo, H., Sallinen, S., Sallinen, P., Helen, P., Jaaskelainen, J., Salmi, T.T., Paetau, A., Paljarvi, L., Visakorpi, T., and Kalimo, H. (1999) Clinicopathological correlation of cell proliferation, apoptosis and p53 in cerebellar pilocytic astrocytomas. Neuropathol. Appl. Neurobiol. 25,134 -142.[Medline]
Haas-Kogan, D.A., Yount, G., Haas, M., Levi, D., Kogan, S.S., Hu, L., Vidair, C., Deen, D.F., Dewey, W.C., and Israel, M.A. (1996) p53dependent G1 arrest and p53independent apoptosis influence the radiobiologic response of glioblastoma. Int. J. Radiat. Oncol. Biol. Phys. 36,95 -103.[CrossRef][ISI][Medline]
Haslam, R.H., Lamborn, K.R., Becker, L.E., and Israel, M.A. (1998) Tumor cell apoptosis present at diagnosis may predict treatment outcome for patients with medulloblastoma. J. Pediatr. Hematol. Oncol. 20,520 -527.[CrossRef][ISI][Medline]
Heesters, M.A., Koudstaal, J., Go, K.G., and Molenaar, W.M. (1999) Analysis of proliferation and apoptosis in brain gliomas: Prognostic and clinical value. J. Neurooncol. 44,255 -266.[CrossRef][Medline]
Kaufmann, S.H., and Earnshaw, W.C. (2000) Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42-49.[CrossRef][ISI][Medline]
Kawauchi, S., Fukuda, T., Oda, Y., Saito, T., Oga, A., Takeshita, M., Yokoyama, K., Chuman, H., Iwamoto, Y., Sasaki, K., and Tsuneyoshi, M. (2000) Prognostic significance of apoptosis in synovial sarcoma: Correlation with clinicopathologic parameters, cell proliferative activity, and expression of apoptosis-related proteins. Mod. Pathol. 13,755 -765.[CrossRef][Medline]
Koike, M. (1996) Significance of spontaneous apoptosis during colorectal tumorigenesis. J. Surg. Oncol. Suppl. 62,97 -108.
Komaki, R., Fujii, T., Perkins, P., Ro, J.Y., Allen, P.K., Mason, K.A., Mountain, C.F., and Milas, L. (1996) Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 36,601 -605.[CrossRef][ISI][Medline]
Kordek, R., Hironishi, M., Liberski, P.P., Yanagihara, R., and Gajdusek, D.C. (1996) Apoptosis in glial tumors as determined by in situ nonradioactive labeling of DNA breaks. Acta Neuropathol. (Berl) 91,112 -116.[Medline]
Korshunov, A., Golanov, A., Sycheva, R., and Pronin, I. (1999) Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: An analysis of 168 cases. J. Clin. Pathol. 52,574 -580.[Abstract]
Leoncini, L., Del Vecchio, M.T., Megha, T., Barbini, P., Galieni, P., Pileri, S., Sabattini, E., Gherlinzoni, F., Tosi, P., Kraft, R. [AU: list all authors] (1993) Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am. J. Pathol. 142,755 -763.[Abstract]
Levine, E.L., Renehan, A., Gossiel, R., Davidson, S.E., Roberts, S.A., Chadwick, C., Wilks, D.P., Potten, C.S., Hendry, J.H., Hunter, R.D. [AU: list all authors] (1995) Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother. Oncol. 37, 1-9.
Lipponen, P., Aaltomaa, S., Kosma, V.M., and Syrjanen, K. (1994) Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur. J. Cancer 30A,2068 -2073.[CrossRef]
Macluskey, M., Baillie, R., Chandrachud, L.M., Pendleton, N., and Schor, A.M. (2000) High levels of apoptosis are associated with improved survival in non-small cell lung cancer. Anticancer Res. 20,2123 -2128.[Medline]
Migheli, A., Cavalla, P., Marino, S., and Schiffer, D. (1994) A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J. Neuropathol. Exp. Neurol. 53,606 -616.[ISI][Medline]
Mommers, E.C., van Diest, P.J., Leonhart, A.M., Meijer, C.J., and Baak, J.P. (1999) Balance of cell proliferation and apoptosis in breast carcinogenesis. Breast Cancer Res. Treat. 58,163 -169.[CrossRef][ISI][Medline]
Nakamura, M., Konishi, N., Tsunoda, S., Hiasa, Y., Tsuzuki, T., Inui, T., and Sakaki, T. (1997) Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma. Cancer 80,242 -249.[CrossRef][ISI][Medline]
Patsouris, E., Davaki, P., Kapranos, N., Davaris, P., and Papageorgiou, K. (1996) A study of apoptosis in brain tumors by in situ end-labeling method. Clin. Neuropathol. 15,337 -341.[Medline]
Rhodes, R.H. (1998) Biological evaluation of biopsies from adult cerebral astrocytomas: Cell-growth/cell-suicide ratios and their relationship to patient survival. J. Neuropathol. Exp. Neurol. 57,746 -757.[Medline]
Schiffer, D., Cavalla, P., Migheli, A., Chio, A., Giordana, M.T., Marino, S., and Attanasio, A. (1995) Apoptosis and cell proliferation in human neuroepithelial tumors. Neurosci. Lett. 195,81 -84.[CrossRef][Medline]
Schiffer, D., Dutto, A., Cavalla, P., Chio, A., Migheli, A., and Piva, R. (1997) Role of apoptosis in the prognosis of oligodendrogliomas. Neurochem. Int. 31,245 -250.[CrossRef][ISI][Medline]
Sebo, T.J. (1995) Digital image analysis. Mayo Clin. Proc. 70,81 -82.[Medline]
Sheridan, M.T., Cooper, R.A., and West, C.M. (1999) A high ratio of apoptosis to proliferation correlates with improved survival after radiotherapy for cervical adenocarcinoma. Int. J. Radiat. Oncol. Biol. Phys. 44,507 -512.[CrossRef][Medline]
Shrieve, D.C., Alexander, E., III, Black, P.M., Wen, P.Y., Fine, H.A., Kooy, H.M., and Loeffler, J.S. (1999) Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: Prognostic factors and long-term outcome. J. Neurosurg. 90,72 -77.[ISI][Medline]
Tanaka, K., Granata, C., Wang, Y., O'Briain, D.S., and Puri, P. (1999) Apoptosis and bcl-2 oncogene expression in Wilms' tumor. Pediatr. Surg. Int. 15,243 -247.[Medline]
Weller, M., Rieger, J., Grimmel, C., Van Meir, E.G., De Tribolet, N., Krajewski, S., Reed, J.C., von Deimling, A., and Dichgans, J. (1998) Predicting chemoresistance in human malignant glioma cells: The role of molecular genetic analyses. Int. J. Cancer 79,640 -644.[CrossRef][ISI][Medline]
Wharton, S.B., Hamilton, F.A., Chan, W.K., Chan, K.K., and Anderson, J.R. (1998) Proliferation and cell death in oligodendrogliomas. Neuropathol. Appl. Neurobiol. 24, 21-28.[ISI][Medline]
Wheeler, J.A., Stephens, L.C., Tornos, C., Eifel, P.J., Ang, K.K., Milas, L., Allen, P.K., and Meyn, R.E., Jr. (1995) ASTRO Research Fellowship: Apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. American Society for Therapeutic Radiology and Oncology. Int. J. Radiat. Oncol. Biol. Phys. 32,1487 -1493.[CrossRef][ISI][Medline]
Xie, X., De Angelis, P., Clausen, O.P., and Boysen, M. (1999) Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas. Oral Oncol. 35,502 -509.[CrossRef][ISI][Medline]
This article has been cited by other articles:
![]() |
K. Heon Seo, H.-M. Ko, H.-A Kim, J.-H. Choi, S. Jun Park, K.-J. Kim, H.-K. Lee, and S.-Y. Im Platelet-Activating Factor Induces Up-regulation of Antiapoptotic Factors in a Melanoma Cell Line through Nuclear Factor-{kappa}B Activation. Cancer Res., May 1, 2006; 66(9): 4681 - 4686. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Shi, S. Bao, J. A. Maxwell, E. D. Reese, H. S. Friedman, D. D. Bigner, X.-F. Wang, and J. N. Rich Secreted Protein Acidic, Rich in Cysteine (SPARC), Mediates Cellular Survival of Gliomas through AKT Activation J. Biol. Chem., December 10, 2004; 279(50): 52200 - 52209. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Porter, B. A. Summers, M. M. Leland, and G. B. Hubbard Glioblastoma Multiforme in Three Baboons (Papio spp) Vet. Pathol., July 1, 2004; 41(4): 424 - 428. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|